NFG
SGMT icon

Nations Financial Group’s Sagimet Biosciences SGMT Stock Holding History

Nations Financial Group’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$92.8K Buy
+12,000
New +$81.6K ﹤0.01% 779
2025
Q2 		– Sell
-15,000
Closed -$48.9K – 696
2025
Q1 		$48.9K Hold
15,000
– – ﹤0.01% 650
2024
Q4 		$67.5K Hold
15,000
– – ﹤0.01% 659
2024
Q3 		$41.5K Hold
15,000
– – ﹤0.01% 666
2024
Q2 		$51.3K Buy
+15,000
New +$68.8K ﹤0.01% 623

Other funds holding SGMT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Nations Financial Group's SGMT Position: Q2 2026 in Review

Nations Financial Group opened a new position in Sagimet Biosciences (SGMT) in Q2 2026: 12,000 shares worth $92.8K. The stake represents ﹤0.01% of the portfolio and ranks #779 among its holdings. This is a return to the name: Nations Financial Group previously reported a position in SGMT as recently as Q1 2025.

Nations Financial Group first reported a position in SGMT in Q2 2024 and has held it in 5 quarters since. 122 funds tracked by Wall St. Rank hold SGMT as of Q2 2026.

  • Nations Financial Group held 12,000 shares of Sagimet Biosciences worth $92.8K as of Q2 2026.
  • Sagimet Biosciences was a new Nations Financial Group position in Q2 2026.
  • Sagimet Biosciences made up ﹤0.01% of Nations Financial Group's portfolio in Q2 2026, its #779 holding.
  • Nations Financial Group first reported a position in Sagimet Biosciences in Q2 2024 and has held it in 5 quarters since.
  • 122 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q2 2026.

Based on Nations Financial Group's 13F filing for Q2 2026, filed 23 Jul 2026.